Table 1 Clinicopathologic characteristics of studied population (n = 78)
From: ERG oncoprotein expression in prostatic acinar adenocarcinoma; clinicopathologic significance
n (%) | |
|---|---|
Age (years) | |
Mean | 69.02 ± 8.82 |
Groups (years) | |
< 40 | 0 (0) |
40–70 | 49 (62.8) |
> 70 | 29 (37.2) |
Tumor quantification | |
Mean | 50.91 ± 30.09 |
Groups (%) | |
< 10 | 11 (14.1) |
10–50 | 24 (30.8) |
> 50 | 43 (55.1) |
Total gleason score | |
6 | 20 (25.6) |
7 | 23 (29.5) |
8 | 4 (5.1) |
9 | 31 (39.7) |
Grade | |
Grade I | 20 (25.6) |
Grade II | 4 (5.1)) |
Grade III | 19 (24.4) |
Grade IV | 4 (5.1) |
Grade V | 31 (39.7) |
Tumor quantification | |
< 10 | 11 (14.1) |
10–50 | 24 (30.8) |
> 50 | 43 (55.1) |
Perineural invasion | |
Present | 25 (32.1) |
Absent | 53 (67.9) |
Lymphovascular invasion | |
Present | 1 (1.3) |
Absent | 77 (98.7) |
Extraprostatic extension | |
Present | 5 (6.4) |
Absent | 73 (93.6) |
Seminal vesicle invasion | |
Present | 4 (5.1) |
Absent | 74 (94.9) |
ERG score | |
Mean | 81.02 ± 111.64 |
Groups | |
No expression | 47 (60.3) |
Low expression | 3 (3.8) |
Intermediate expression | 10 (12.8) |
High expression | 18 (23.1) |